Answers are grounded in this paper and cite their sources.
Prostaglandin (PGE2) drives tumor progression but the pathway has not been effectively drugged. We demonstrate significantly enhanced immunologic potency and antitumor activity through blockade of EP2 and EP4 PGE2 receptor signaling together with a single molecule.
No takes yet. Share an insight, caveat, or question.
Francica et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: